Rocket Pharmaceuticals (RCKT) Insider Trading & Ownership $3.35 +0.03 (+0.90%) Closing price 04:00 PM EasternExtended Trading$3.37 +0.02 (+0.72%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Rocket Pharmaceuticals (NASDAQ:RCKT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.76%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$234.87KNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$341.52K Get RCKT Insider Trade Alerts Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RCKT Insider Buying and Selling by Quarter Rocket Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/27/2025Elisabeth BjorkDirectorBuy10,000$3.41$34,100.00 8/19/2025John MilitelloInsiderSell361$3.00$1,083.00 8/19/2025Jonathan David SchwartzInsiderSell805$3.00$2,415.00 8/19/2025Martin WilsonGeneral CounselSell588$3.00$1,764.00 8/18/2025John MilitelloInsiderSell699$3.06$2,138.94 8/18/2025Jonathan David SchwartzInsiderSell1,680$3.06$5,140.80 8/18/2025Martin WilsonGeneral CounselSell1,004$3.06$3,072.24 8/14/2025John MilitelloInsiderSell7,043$3.02$21,269.86 8/14/2025Jonathan David SchwartzInsiderSell11,161$3.02$33,706.22 8/14/2025Martin WilsonGeneral CounselSell12,109$3.02$36,569.18 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/3/2025Aaron OndreyCFOSell1,477$2.88$4,253.76 4/22/2025John MilitelloInsiderSell718$7.16$5,140.88 4/10/2025Gaurav ShahCEOBuy20,000$5.08$101,600.00 4/9/2025Kinnari PatelInsiderBuy21,099$4.70$99,165.30 4/4/2025Aaron OndreyCFOSell7,489$5.29$39,616.81 1/23/2025John MilitelloInsiderSell896$10.38$9,300.48 11/21/2024Gaurav ShahCEOSell11,091$13.05$144,737.55 11/21/2024John MilitelloInsiderSell1,224$13.05$15,973.20 11/21/2024Martin WilsonGeneral CounselSell1,175$13.05$15,333.75 (Data available from 1/1/2013 forward) RCKT Insider Trading Activity - Frequently Asked Questions Who is on Rocket Pharmaceuticals' Insider Roster? The list of insiders at Rocket Pharmaceuticals includes Aaron Ondrey, David P Southwell, Elisabeth Bjork, Gaurav Shah, Gotham Makker, John Militello, Jonathan David Schwartz, Kinnari Patel, Mark Andrew White, Martin Wilson, and Rtw Investments, Lp. Learn more on insiders at RCKT. What percentage of Rocket Pharmaceuticals stock is owned by insiders? 24.76% of Rocket Pharmaceuticals stock is owned by insiders. Learn more on RCKT's insider holdings. Which Rocket Pharmaceuticals insiders have been buying company stock? The following insiders have purchased RCKT shares in the last 24 months: Elisabeth Bjork ($34,100.00), Gaurav Shah ($101,600.00), and Kinnari Patel ($99,165.30). How much insider buying is happening at Rocket Pharmaceuticals? Insiders have purchased a total of 51,099 RCKT shares in the last 24 months for a total of $234,865.30 bought. Which Rocket Pharmaceuticals insiders have been selling company stock? The following insiders have sold RCKT shares in the last 24 months: Aaron Ondrey ($43,870.57), David P Southwell ($1,945,700.00), Gaurav Shah ($978,250.53), Gotham Makker ($8,457,281.36), John Militello ($513,188.40), Jonathan David Schwartz ($41,262.02), Kinnari Patel ($212,818.88), Mark Andrew White ($370,488.62), and Martin Wilson ($308,170.81). How much insider selling is happening at Rocket Pharmaceuticals? Insiders have sold a total of 521,724 Rocket Pharmaceuticals shares in the last 24 months for a total of $12,871,031.19 sold. Rocket Pharmaceuticals Key ExecutivesMs. Kinnari Patel M.B.A. (Age 44)Pharm.D., Head of R&D, President & COO Compensation: $849.93k1 recent tradesMr. Mayo Pujols (Age 54)Chief Technical Officer Compensation: $649.71kMr. Raj Prabhakar M.B.A. (Age 49)Chief Business Officer Compensation: $619.13kMr. Aaron Ondrey (Age 47)Chief Financial Officer 2 recent tradesMr. Martin Louis Wilson J.D. (Age 48)General Counsel, Chief Compliance Officer & Chief Corporate Officer Compensation: $149.95kKevin GiordanoDirector of Corporate CommunicationsMs. Isabel Carmona J.D.Chief People OfficerMr. Jonathan Schwartz M.D. (Age 59)Chief Medical & Gene Therapy Officer Compensation: $557.79kDr. Gayatri R. Rao J.D.M.D., Senior VP of Clinical Safety & Chief Regulatory OfficerMr. Carlos MartinChief Commercial Operations & Revenue Officer More Insider Trading Tools from MarketBeat Related Companies Phibro Animal Health Insider Ownership Xeris Biopharma Insider Ownership Enliven Therapeutics Insider Ownership Collegium Pharmaceutical Insider Ownership Intellia Therapeutics Insider Ownership Structure Therapeutics Insider Ownership Tilray Brands Insider Ownership Arcus Biosciences Insider Ownership LENZ Therapeutics Insider Ownership Spyre Therapeutics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:RCKT) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access